Evommune EVMN
NYSE EVMN
$8.31 -0.08 (-0.95%)
As of: Sep 29, 2026 · 3:59 PM EDT

Evommune (EVMN) EPS (Diluted) (2024 - 2026)

Updated

Evommune's EPS (Diluted) came in at -$0.89 for Q2 2026, compared with -$8.80 a year earlier.

Analysis

Evommune (EVMN) EPS (Diluted) (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Evommune reported EPS (Diluted) of -$2.62; for FY2025, it came in at -$11.22.

  • Going back by year, EPS (Diluted) was -$44.29 in FY2024.
  • The five-year range for quarterly EPS (Diluted) is -$13.74 (Q4 2024) to -$0.64 (Q1 2026).
  • Business Quant data shows EVMN's EPS (Diluted) at -$0.64 (Q1 2026), -$4.61 (Q4 2025) and -$8.07 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 2.27
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.04
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -0.54
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 1.67
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 1.85
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.37
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -8.44
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 4.31
10 Evommune 304.40 Mn -333.11 Mn - -0.89
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.89
Mar 31, 2026 -0.64
Dec 31, 2025 -4.61
Sep 30, 2025 -8.07
Jun 30, 2025 -8.80
Mar 31, 2025 -9.48
Dec 31, 2024 -13.74
Sep 30, 2024 -10.47
API Access

Evommune EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=EVMN&period=max&api_key=YOUR_API_KEY